Export of sphingosine-1-phosphate and cancer progression

被引:131
作者
Takabe, Kazuaki [1 ,2 ]
Spiegel, Sarah [2 ]
机构
[1] Virginia Commonwealth Univ, Div Surg Oncol, Dept Surg, Sch Med, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA
基金
美国国家卫生研究院;
关键词
ATP binding cassette transporter; sphingosine kinase; tumor microenvironment; angiogenesis; lymphangiogenesis; SPHINGOSINE KINASE 1; PERSISTENT STAT3 ACTIVATION; BREAST-CANCER; TRANSPORTER SPNS2; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; SPHINGOLIPID METABOLISM; SPROUTING ANGIOGENESIS; VASCULAR DEVELOPMENT; GLIOBLASTOMA CELLS;
D O I
10.1194/jlr.R046656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator that promotes cell survival, proliferation, migration, angiogenesis, lymphangiogenesis, and immune response; all are critical processes of cancer progression. Although some important roles of intracellular S1P have recently been uncovered, the majority of its biological effects are known to be mediated via activation of five specific G protein-coupled receptors [S1P receptor (S1PR) 1-S1PR5] located on the cell surface. Secretion of S1P produced inside cells by sphingosine kinases can then signal through these receptors in autocrine, paracrine, and/or endocrine manners, coined "inside-out" signaling of S1P. Numerous studies suggest that secreted S1P plays important roles in cancer progression; thus, understanding the mechanism by which S1P is exported out of cells, particularly cancer cells, is both interesting and important. jlr Here we will review the current understanding of the transport of S1P out of cancer cells and its potential roles in the tumor microenvironment.
引用
收藏
页码:1839 / 1846
页数:8
相关论文
共 50 条
  • [21] The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer
    Hait, Nitai C.
    Maiti, Aparna
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [22] Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer
    Katsuta, Eriko
    Yan, Li
    Nagahashi, Masayuki
    Raza, Ali
    Sturgill, Jamie L.
    Lyon, Debra E.
    Rashid, Omar M.
    Hait, Nitai C.
    Takabe, Kazuaki
    JOURNAL OF SURGICAL RESEARCH, 2017, 219 : 202 - 213
  • [23] Sphingosine-1-phosphate receptor 2
    Adada, Mohamad
    Canals, Daniel
    Hannun, Yusuf A.
    Obeid, Lina M.
    FEBS JOURNAL, 2013, 280 (24) : 6354 - 6366
  • [24] Role of sphingosine-1-phosphate receptors in the tumor microenvironment: prospects for cancer immunotherapy
    Wang, Z.
    Zhang, H. -M.
    Guo, Y. -R
    LI, L. -l.
    Zhang, G. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (02) : 713 - 727
  • [25] The Role of Sphingosine-1-Phosphate in Breast Cancer Tumor-Induced Lymphangiogenesis
    Aoyagi, Tomoyoshi
    Nagahashi, Masayuki
    Yamada, Akimitsu
    Takabe, Kazuaki
    LYMPHATIC RESEARCH AND BIOLOGY, 2012, 10 (03) : 97 - 106
  • [26] Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks
    Riboni, Laura
    Hadi, Loubna Abdel
    Navone, Stefania Elena
    Guarnaccia, Laura
    Campanella, Rolando
    Marfia, Giovanni
    CELLS, 2020, 9 (02)
  • [27] Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis
    Huang, Wei-Ching
    Nagahashi, Masayuki
    Terracina, Krista P.
    Takabe, Kazuaki
    BIOMOLECULES, 2013, 3 (03): : 408 - 434
  • [28] Endothelial Functions of Sphingosine-1-phosphate
    Lucke, Susann
    Levkau, Bodo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 26 (01) : 87 - 96
  • [29] The roles of sphingosine-1-phosphate in asthma
    Jolly, PS
    Rosenfeldt, HM
    Milstien, S
    Spiegel, S
    MOLECULAR IMMUNOLOGY, 2002, 38 (16-18) : 1239 - 1245
  • [30] Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors
    Heringdorf, DMZ
    Lass, H
    Kuchar, I
    Lipinski, M
    Alemany, R
    Rümenapp, U
    Jakobs, KH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 414 (2-3) : 145 - 154